Anti-Aging Company Announces Marine D3 Review After Department of Health Report Reveals Connection Between Cholesterol and Stroke (amazon) (shopzilla)

Houston, TX. (PRWEB) September 30, 2012

After the Department of Health released a new report last week, indicating the importance of controlling cholesterol, announced a new review of the Marine D3 product, an anti-aging supplement designed to help people control their cholesterol levels. This product is designed to help people with the aging process by lowering bad cholesterol levels, improving circulating and helping with joint stiffness and pain. The company hopes that the new product review, along with these reports and dire warnings from the Department of Health will encourage more people to look into ways they can control and lower their bad cholesterol levels.

The Department of Healths new report details how you can reduce your chances of having a stroke or developing heart disease by learning the difference between good cholesterol and bad cholesterol and taking additional steps to lower bad cholesterol in the body. Reports from the Department of Health have shown that those who take the initiative to lower their cholesterol levels have a better chance of living longer healthier lives. This is why the anti aging company has announced their new free review of Marine D3; so those interested in lowering their cholesterol and improving their quality of life can see if this product will help them.

For more information on the Department of Healths new report; titled Cholesterol: Friend and Enemy of Aging view the report online, to see what professionals are saying about the dangerous of high cholesterol. To find out more about Marine D3 and how it can help lower these cholesterol levels visit The companys new review has recently launched on the company website and is available for any individual interested in learning more about lowering their cholesterol.

To find out more about the company and the best anti-aging solutions available in todays market, visit:

Related Blogs

    Over the Counter Product Developed for Stroke Victims is Making People Look 5 or More Years Younger as Sales Chanel Lifts Sales at Liberty Health Network – @GoLHN (amazon) (shopzilla)

    Tampa – St Petersburg, FL (PRWEB) April 25, 2012

    Call it a massive success. A free shipping promotion has sales of the Beau Visage Facelift Mask are up again for the two week pay cycle with online sales giant Amazon.Com. Liberty Health Network, LLC (LHN) is in the midst of an impressive run of sales in the Amazon sales chanel lifting company revenues impressively.

    “Amazon processes payments to vendors every two weeks. We use these payments as a benchmark as to the performance in the Amazon cosmetics chanel. The growth in terms of overall product sales, sales per order, average order value… You name it; All numbers are up and up each and every cycle for months now!” Said LHN’s Chief Financial Officer Tracy Grevert.

    “Sales are up because we guarantee our products work. They work for men. They work for women. And, the word is spreading. We’re seeing a steady increase in repeat business. We’re seeing an increase in word-of-mouth referrals. We’re seeing an increase in customers inquiring about our business opportunity to sell Beau Visage products. Amazon’s sales chanel lifts revenues and increases exposure for our products like no other online investment.” Said Russell Bly, Chief operating Officer with Liberty Health Network.

    The Beau Visage product with the biggest success is the Non Surgical Facelift Mask. Originally developed for stroke victims, this aloe-based product helps lift sags, firm skin, and reduce wrinkles. Both men and women report success with the Beau Visage Facial Skin Products.

    LHN also reports that sales of Nutritional Supplements are looking favorable with Amazon as well. The company has seen an increase in sales of the Antioxidant Weight Loss Supplement SlimEZ, and an increase in sales of the company’s AlliStar Garlic Allicin – Ginger – Star Anise supplement as well.

    When asked if he saw the company moving out of other direct sales chanels in favor of amazon, Bly responded “While we love our relationship with Amazon.Com, this portal only represents a small portion of corporate sales. Amazon is not meant to replace other sales chanels, but to support sales chanels by increasing name recognition and marketplace credibility. Our continuing success on Amazon helps all of our marketing partners.”

    About Liberty Health Network, LLC

    Liberty Health Network is one of the nations leading Direct and Internet Marketing companies with a state-of-the-art Global Distribution facility in Tampa Bay, Fl. For 12 Years, the Liberty Health Network name has been synonymous with high quality Mortechem-Free Nutritional Supplements, Anti Aging Skin Care, and Internet Web Applications. The statements made on this website have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, prevent, treat, or cure any disease.

    Businesses or Individuals interested in distributing Liberty Products or requiring more information on this topic should contact Chief Operating Officer Russell Bly at (813) 774-8191 or e-mail at office(at)libertyhealthbiz(dot)com.

    Related Anti Aging Supplements For Men Press Releases

    Related Blogs

      Minocycline Enhances the Efficacy of Perispinal Enbrel in Traumatic Brain Injury Treatment as well as Stroke Treatment and Alzheimers Treatment (amazon) (shopzilla)

      (PRWEB) March 08, 2013

      This study, soon to be published in the British Journal of Pharmacology and available now as an abstract online, delineates the mechanisms by which minocycline reduces inflammation. This peer-reviewed article critically reviews recent human and animal research demonstrating the potential for minocycline to provide neuroprotection and ameliorate the impairments experienced by those affected by traumatic brain injury (TBI), stroke and Alzheimer’s disease. The authors elucidate how minocycline exerts neuroprotective and neuroregenerative effects in response to TBI, stroke and Alzheimer’s. These processes are entirely different from those of etanercept. Perispinally administered etanercept inhibits the production of TNF-alpha in the brain. Minocycline also inhibits the production of TNF-alpha as well as a number of related cytokines. In 2012 Augusto Ramirez, M.D., began treating TBI, stroke and Alzheimers patients with perispinal Enbrel coupled with oral minocycline. The result has been improved outcomes. This article: Minocycline: Far beyond an Antibiotic provides broad scientific rationale for the inclusion of oral minocycline adjunctively with perispinally administered etanercept for the treatment of TBI, stroke and Alzheimer’s disease.

      Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around the world to their Center in Managua, Nicaragua for individualized instructional courses teaching this procedure. Presently Neurological Wellness Center remains the only institution in the world teaching this perispinal Enbrel injection procedure. For more information about Neurological Wellness Centers perispinal injection courses visit:

      For many, flying to Managua, Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at

      Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

      Neuroinflammation contributes to a portion of the impairments people with Traumatic Brain Injury, stroke and Alzheimers disease experience. Last year a study published in the Journal CNS Drugs and available online:, systematically examined the clinical responses of 629 patients afflicted by stroke or traumatic brain injury following the perispinal administration of Enbrel (Etanercept). The mean age of the stroke patients was 65.8 years. The mean interval between stroke and perispinal Enbrel treatment (PSE) was 42.0 months. The mean age of the traumatic brain injury (TBI) patients was 34.7 years. The mean interval between TBI and PSE treatment was 115 months.

      Comprehensive pre-treatment and post-treatment assessments were made, with particular attention given to motor function, walking, pain, sensation, cognition and mood. A variety of standardized instruments were utilized in making these assessments. Neurological Wellness Center finds the results of this study to be extraordinarily noteworthy, not simply for the degree of the improvements observed but also for the extent of improvements across many areas of assessment. Equally striking was the rapidity of the improvement. Observations such as rapid motor improvement beginning within minutes: was routinely observed in both post-stroke and the TBI patients are ubiquitous throughout this observational study. The fact that the mean interval between stroke and PSE was 42.0 months and TBI and PSE 115 months makes these results even more remarkable. These results herald a new paradigm of understanding stroke and traumatic brain injury; whereby a self-perpetuating cascade of inflammation is produced in response to the trauma and the on-going inflammation contributes substantially to the impairments people experience. Once this inflammation is attenuated, significant recovery of physical and cognitive function becomes a reality these people experience often for the first time in years.

      “The addition of minocycline to our treatment protocol has resulted in improved treatment outcomes.” Augusto Ramirez M.D.

      Dr. Steve Ralph, Associate Professor at Griffith University School of Medicine in Australia came to our Neurological Wellness Center in Managua and received instruction in perispinal Enbrel injection procedure. Dr. Ralph has stated; “These results represent a sea change in therapeutic possibilities for stroke and TBI patients. I have observed first hand rapid clinical improvement in patients. Rarely do we see such a radical breakthrough in medical treatment as this.”

      The TBI treatment, stroke treatment and Alzheimers treatment protocols Dr. Augusto Ramirez utilizes all involve combining perispinal Enbrel injections with oral minocycline. Additionally, he advises supplementing with N-acetylcysteine, fish oil and astaxanthin. To learn more about ameliorating the impairments caused by TBI, stroke and Alzheimers disease by reducing inflammation in the brain visit: To schedule a personal hands-on training covering all aspects of perispinal Enbrel injection procedure visit: For the lowest Enbrel price in North American visit:


      Clinical Trial; Minocycline in patients with Alzheimer’s disease.


      Clinical Trial; Minocycline treatment in acute stroke; An open label, evaluator-blinded study.


      Clinical Trial; Safety of minocycline in the treatment of traumatic brain injury (TBI)


      Minocycline to improve neurologic outcome in stroke; a dose-finding study.


      Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer’s disease models.


      Minocycline reduces the development of abnormal tau species in models of Alzheimer’s disease.


      Analysis of the antibiotic minocycline as a treatment for dementia.


      Minocycline reduces traumatic brain injury-mediated capase-1 activation , tissue damage and neurological dysfunction.

      Therapeutic evaluation of etanercept in a model of traumatic brain injury.

      Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.

      Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates. with the volume of evolving brain infarct.

      Perispinal etanercept for neuroinflammatory disorders.

      Inflammatory cytokines in acute ischemic stroke.;year=2012;volume=60;issue=1;spage=23;epage=28;aulast=Padma

      Efficacy of minocycline in acute ischemic stroke: A single-blinded, placebo-controlled trial.

      Related Blogs

        Subscribe By Email for Weekly Updates.